The DOI matches its Crossref record; 114 of the 114 references it cites were found in a registry or an index.
Clinical spectrum of levodopa‐induced complications
Abstract
The first years of Parkinson disease (PD) treatment are marked by good and sustained responses to dopaminergic therapy. With disease progression and longer exposure to levodopa (l‐dopa), patients develop a range of l‐dopa–induced complications that include motor and non‐motor symptoms. Motor complications include motor fluctuations, characterized by periods of reduced benefit from the medication, and l‐dopa–induced dyskinesia, characterized by emergence of hyperkinetic involuntary movements. Dyskinesia can occur at peak effect of l‐dopa, at the beginning and end of dose, or between doses. These motor complications are often associated with fluctuations in non‐motor symptoms, particularly fluctuations in neuropsychiatric, autonomic, and sensory symptoms. Recognizing such complications and understanding their relationship with the timing of l‐dopa doses is essential for adequate diagnosis and management. © 2014 International Parkinson and Movement Disorder Society
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Goetz, C. G., Tilley, B. C., Shaftman, S. R., Stebbins, G. T., Fahn, S., Martinez‐Martin, P., Poewe, W., Sampaio, C., Stern, M. B., Dodel, R., et al. (2008) · Movement Disorders · doi:10.1002/mds.22340 · Cited by 7,536
The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years
Hely, M. A., Reid, W. G. J., Adena, M. A., Halliday, G. M., & Morris, J. G. L. (2008) · Movement Disorders · doi:10.1002/mds.21956 · Cited by 2,246
Levodopa and the Progression of Parkinson's Disease
(2004) · New England Journal of Medicine · doi:10.1056/nejmoa033447 · Cited by 1,821
Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment
Chaudhuri, K. R., & Schapira, A. H. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70068-7 · Cited by 1,738
Rascol, O., Brooks, D. J., Korczyn, A. D., De Deyn, P. P., Clarke, C. E., & Lang, A. E. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005183422004 · Cited by 1,539
Ahlskog, J. E., & Muenter, M. D. (2001) · Movement Disorders · doi:10.1002/mds.1090 · Cited by 1,454
A double‐blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease
Olanow, C. W., Goetz, C. G., Kordower, J. H., Stoessl, A. J., Sossi, V., Brin, M. F., Shannon, K. M., Nauert, G. M., Perl, D. P., Godbold, J., et al. (2003) · Annals of Neurology · doi:10.1002/ana.10720 · Cited by 1,307
Modification of Parkinsonism — Chronic Treatment with L-Dopa
Cotzias, G. C., Papavasiliou, P. S., & Gellene, R. (1969) · New England Journal of Medicine · doi:10.1056/nejm196902132800701 · Cited by 1,284
Seppi, K., Weintraub, D., Coelho, M., Perez‐Lloret, S., Fox, S. H., Katzenschlager, R., Hametner, E., Poewe, W., Rascol, O., Goetz, C. G., et al. (2011) · Movement Disorders · doi:10.1002/mds.23884 · Cited by 1,141
Self-citationChaudhuri, K. R., Martinez‐Martin, P., Brown, R. G., Sethi, K., Stocchi, F., Odin, P., Ondo, W., Abe, K., MacPhee, G., MacMahon, D., et al. (2007) · Movement Disorders · doi:10.1002/mds.21596 · Cited by 1,087
Olanow, C. W., Kieburtz, K., Odin, P., Espay, A. J., Standaert, D. G., Fernandez, H. H., Vanagunas, A., Othman, A. A., Widnell, K. L., Robieson, W. Z., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70293-x · Cited by 716
"ON-OFF" EFFECTS IN PATIENTS WITH PARKINSON'S DISEASE ON CHRONIC LEVODOPA THERAPY
Marsden, C. D., & Parkes, J. D. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91416-1 · Cited by 661
Nonmotor fluctuations in Parkinson’s disease: Frequent and disabling
Witjas, T., Kaphan, E., Azulay, J. P., Blin, O., Ceccaldi, M., Pouget, J., Poncet, M., & Chérif, A. A. (2002) · Neurology · doi:10.1212/wnl.59.3.408 · Cited by 642
SUCCESS AND PROBLEMS OF LONG-TERM LEVODOPA THERAPY IN PARKINSON'S DISEASE
Marsden, C. D., & Parkes, J. D. (1977) · The Lancet · doi:10.1016/s0140-6736(77)91146-1 · Cited by 587
(2004) · Archives of Neurology · doi:10.1001/archneur.61.7.1044 · Cited by 561
Motor fluctuations and dyskinesias in Parkinson's disease: Clinical manifestations
Jankovic, J. (2005) · Movement Disorders · doi:10.1002/mds.20458 · Cited by 547
Molecular mechanisms of L-DOPA-induced dyskinesia
Jenner, P. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2471 · Cited by 523
Thenganatt, M. A., & Jankovic, J. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2013.6233 · Cited by 506
Pathophysiology of levodopa-induced dyskinesia: Potential for new therapies
Bezard, E., Brotchie, J. M., & Gross, C. E. (2001) · Nature Reviews Neuroscience · doi:10.1038/35086062 · Cited by 503
Warren Olanow, C., Kieburtz, K., Rascol, O., Poewe, W., Schapira, A. H., Emre, M., Nissinen, H., Leinonen, M., Stocchi, F., & Stalevo Reduction in Dyskinesia Evaluation in Parkinson's Disease (STRIDE‐PD) Investigators (2013) · Movement Disorders · doi:10.1002/mds.25364 · Cited by 484
Young onset Parkinson's disease
Quinn, N., Critchley, P., & Marsden, C. D. (1987) · Movement Disorders · doi:10.1002/mds.870020201 · Cited by 443
Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap
Calabresi, P., Filippo, M. D., Ghiglieri, V., Tambasco, N., & Picconi, B. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70218-0 · Cited by 388
Nonmotor fluctuations in Parkinson disease: Severity and correlation with motor complications
Storch, A., Schneider, C. B., Wolz, M., Stürwald, Y., Nebe, A., Odin, P., Mahler, A., Fuchs, G., Jost, W. H., Chaudhuri, K. R., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e318285c0ed · Cited by 372
Brown, R. G., Dittner, A., Findley, L., & Wessely, S. C. (2005) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2004.07.007 · Cited by 361
Levodopa‐induced dyskinesia: Review, observations, and speculations
Nutt, M. (1990) · Neurology · doi:10.1212/wnl.40.2.340 · Cited by 358
Cilia, R., Akpalu, A., Sarfo, F. S., Cham, M., Amboni, M., Cereda, E., Fabbri, M., Adjei, P., Akassi, J., Bonetti, A., et al. (2014) · Brain · doi:10.1093/brain/awu195 · Cited by 339
Swallowing abnormalities and their response to treatment in Parkinson's disease
Bushmann, M., Dobmeyer, S. M., Leeker, L., & Perlmutter, J. S. (1989) · Neurology · doi:10.1212/wnl.39.10.1309 · Cited by 318
Goetz, C. G., Tanner, C. M., Levy, M., Wilson, R. S., & Garron, D. C. (1986) · Movement Disorders · doi:10.1002/mds.870010106 · Cited by 308
Fluctuations of disability in Parkinson's disease – clinical aspects
Marsden, C. D., Parkes, J. D., & Quinn, N. (1981) · Movement Disorders · doi:10.1016/b978-0-407-02295-9.50012-6 · Cited by 284
Pathophysiology of somatosensory abnormalities in Parkinson disease
Conte, A., Khan, N., Defazio, G., Rothwell, J. C., & Berardelli, A. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.224 · Cited by 280
SHOULSON, I., GLAUBIGER, G. A., & CHASE, T. N. (1975) · Neurology · doi:10.1212/wnl.25.12.1144 · Cited by 278
Primary sensory symptoms in parkinsonism
SNIDER, S. R., FAHN, S., ISGREEN, W. P., & COTE, L. J. (1976) · Neurology · doi:10.1212/wnl.26.5.423 · Cited by 277
Fourteen-year final report of the randomized PDRG-UK trial comparing three initial treatments in PD
Katzenschlager, R., Head, J., Schrag, A., Ben-Shlomo, Y., Evans, A., & Lees, A. J. (2008) · Neurology · doi:10.1212/01.wnl.0000310812.43352.66 · Cited by 271
Hauser, R. A., Rascol, O., Korczyn, A. D., Jon Stoessl, A., Watts, R. L., Poewe, W., De Deyn, P. P., & Lang, A. E. (2007) · Movement Disorders · doi:10.1002/mds.21743 · Cited by 252
Muenter, M. D., & Tyce, G. M. (1971) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(25)07667-0 · Cited by 248
Non-motor Parkinson's: integral to motor Parkinson's, yet often neglected
Todorova, A., Jenner, P., & Ray Chaudhuri, K. (2014) · Practical Neurology · doi:10.1136/practneurol-2013-000741 · Cited by 247
Stacy, M., Bowron, A., Guttman, M., Hauser, R., Hughes, K., Larsen, J. P., LeWitt, P., Oertel, W., Quinn, N., Sethi, K., et al. (2005) · Movement Disorders · doi:10.1002/mds.20383 · Cited by 246
Levodopa‐induced dyskinesias in Parkinson's disease phenomenology and pathophysiology
Marconi, R., Lefebvre‐Caparros, D., Bonnet, A., Vidailhet, M., Dubois, B., & Agid, Y. (1994) · Movement Disorders · doi:10.1002/mds.870090103 · Cited by 237
Levodopa‐induced dyskinesias in Parkinson's disease: Clinical and pharmacological classification
Luquin, M. R., Scipioni, O., Vaamonde, J., Gershanik, O., & Obeso, J. A. (1992) · Movement Disorders · doi:10.1002/mds.870070204 · Cited by 235
The expanding universe of disorders of the basal ganglia
Obeso, J. A., Rodriguez-Oroz, M. C., Stamelou, M., Bhatia, K. P., & Burn, D. J. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62418-6 · Cited by 230
FAHN, S. (1974) · Neurology · doi:10.1212/wnl.24.5.431 · Cited by 230
Krack, P. (1999) · Brain · doi:10.1093/brain/122.6.1133 · Cited by 229
Ha, A. D., & Jankovic, J. (2012) · Movement Disorders · doi:10.1002/mds.23959 · Cited by 223
Quinn, N. P., Lang, A. E., Koller, W. C., & Marsden, C. D. (1986) · The Lancet · doi:10.1016/s0140-6736(86)91674-0 · Cited by 217
Autonomic Dysfunction in Parkinson's Disease
Koike, Y., & Takahashi, A. (1997) · European Neurology · doi:10.1159/000113470 · Cited by 211
Response of parkinsonian swallowing dysfunction to dopaminergic stimulation
Hunter, P. C., Crameri, J., Austin, S., Woodward, M. C., & Hughes, A. J. (1997) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.63.5.579 · Cited by 197
Autonomic dysfunction in Parkinson's disease
Goetz, C. G., Lutge, W., & Tanner, C. M. (1986) · Neurology · doi:10.1212/wnl.36.1.73 · Cited by 192
Tracey, I., Becerra, L., Chang, I., Breiter, H., Jenkins, L., Borsook, D., & González, R. G. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01224-6 · Cited by 179
Graft‐induced dyskinesias in Parkinson's disease: High striatal serotonin/dopamine transporter ratio
Politis, M., Oertel, W. H., Wu, K., Quinn, N. P., Pogarell, O., Brooks, D. J., Bjorklund, A., Lindvall, O., & Piccini, P. (2011) · Movement Disorders · doi:10.1002/mds.23743 · Cited by 175
Sweating dysfunction in Parkinson's disease
Swinn, L., Schrag, A., Viswanathan, R., Bloem, B. R., Lees, A., & Quinn, N. (2003) · Movement Disorders · doi:10.1002/mds.10586 · Cited by 169
Manson, A., Stirpe, P., & Schrag, A. (2012) · Journal of Parkinson’s Disease · doi:10.3233/jpd-2012-120103 · Cited by 167
Dystonia in parkinson's disease: Clinical and pharmacological features
Poewe, W. H., Lees, A. J., & Stern, G. M. (1988) · Annals of Neurology · doi:10.1002/ana.410230112 · Cited by 162
Classification of fluctuations in patients with Parkinson's disease
Quinn, N. P. (1998) · Neurology · doi:10.1212/wnl.51.2_suppl_2.s25 · Cited by 158
Anal Sphincter Dysfunction in Parkinson's Disease
Mathers, S. E., Kempster, P. A., Law, P. J., Frankel, J. P., Bartram, C. I., Lees, A. J., Stern, G. M., & Swash, M. (1989) · Archives of Neurology · doi:10.1001/archneur.1989.00520460037010 · Cited by 158
The spectrum of levodopa‐related fluctuations in Parkinson's disease
Riley, D. E., & Lang, A. E. (1993) · Neurology · doi:10.1212/wnl.43.8.1459 · Cited by 155
Hagelberg, N. M., Martikainen, I. K., Mansikka, H. T., Hinkka‐Yli‐Salomäki, S., Någren, K., Hietala, J. A., Scheinin, H., & Pertovaara, A. (2002) · Pain · doi:10.1016/s0304-3959(02)00121-5 · Cited by 152
Patterns of dystonia ("I-D-I" and "D-I-D-") in response to l-dopa therapy for Parkinson's disease.
Muenter, M. D., Sharpless, N. S., Tyce, G. M., & Darley, F. L. (1977) · PubMed · Cited by 151
BDNF val66met influences time to onset of levodopa induced dyskinesia in Parkinson's disease
Foltynie, T., Cheeran, B., Williams‐Gray, C. H., Edwards, M. J., Schneider, S. A., Weinberger, D. R., Rothwell, J. C., Barker, R., & Bhatia, K. P. (2008) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.154294 · Cited by 150
Nonmotor fluctuations in patients with Parkinson's disease
Hillen, M. E., & Sage, J. I. (1996) · Neurology · doi:10.1212/wnl.47.5.1180 · Cited by 145
Blanchet, P. J., Calon, F., Martel, J.-C., Bédard, P. J., Paolo, T. D., Walters, R. R., & Piercey, M. F. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24503-7 · Cited by 142
Effect of subthalamic deep brain stimulation on the function of the urinary bladder
Seif, C., Herzog, J., van der Horst, C., et al. (2003) · Annals of Neurology · doi:10.1002/ana.10806 · Cited by 142
ROLE OF SUBCUTANEOUS APOMORPHINE IN PARKINSONIAN VOIDING DYSFUNCTION
CHRISTMAS, T. J., Chapple, C. R., Lees, A. J., et al. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90932-4 · Cited by 142
Engber, T. M., Susel, Z., Juncos, J. L., & Chase, T. N. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90790-5 · Cited by 133
Validation of the MDS‐UPDRS Part I for nonmotor symptoms in Parkinson's disease
Gallagher, D. A., Goetz, C. G., Stebbins, G. T., Lees, A. J., & Schrag, A. E. (2011) · Movement Disorders · doi:10.1002/mds.23939 · Cited by 126
Akathisia in idiopahic Parkinson's disease
Lang, A. E., & Johnson, K. (1987) · Neurology · doi:10.1212/wnl.37.3.477 · Cited by 122
Uchiyama, T., Sakakibara, R., Hattori, T., & Yamanishi, T. (2003) · Movement Disorders · doi:10.1002/mds.10403 · Cited by 118
Akathisia, restless legs and periodic limb movements in sleep in Parkinson’s disease
Poewe, W. H., & Högl, B. (2004) · Neurology · doi:10.1212/wnl.63.8_suppl_3.s12 · Cited by 117
Autonomic dysfunction in Parkinson disease
Kaufmann, H., & Goldstein, D. S. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-444-53491-0.00021-3 · Cited by 107
Assessing the non‐motor symptoms of Parkinson's disease: MDS ‐ UPDRS and NMS Scale
Martínez‐Martín, P., Chaudhuri, К. R., Rojo-Abuín, J. M., Rodríguez‐Blázquez, C., Álvarez, M., Arakaki, T., Bergareche‐Yarza, A., Chade, A. R., Garretto, N., Gershanik, O. S., et al. (2013) · European Journal of Neurology · doi:10.1111/ene.12165 · Cited by 107
Early-Morning Dystonia: A Late Side Effect of Long-term Levodopa Therapy in Parkinson's Disease
Melamed, E. (1979) · Archives of Neurology · doi:10.1001/archneur.1979.00500410086014 · Cited by 106
Axial kinesthesia is impaired in Parkinson's disease: Effects of levodopa
Wright, W. G., Gurfinkel, V. S., King, L. A., Nutt, J. G., Cordo, P. J., & Horak, F. B. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.06.016 · Cited by 104
Micturition Disturbance in Parkinson's Disease
FITZMAURICE, H., Fowler, C. J., Rickards, D., Kirby, R. S., Quinn, N. P., MARSDEN, C. D., Milroy, E. J. G., & Turner-Warwick, R. T. (1985) · British Journal of Urology · doi:10.1111/j.1464-410x.1985.tb07025.x · Cited by 104
Klawans, H. L., Goetz, C. G., & Bergen, D. C. (1975) · Archives of Neurology · doi:10.1001/archneur.1975.00490470075011 · Cited by 103
Perez‐Lloret, S., Nègre‐Pagès, L., Senard, A., Damier, P., Destée, A., Tison, F., Merello, M., Rascol, O., & for the COPARK Study Group (2011) · European Journal of Neurology · doi:10.1111/j.1468-1331.2011.03402.x · Cited by 102
Effects of dopaminergic treatment on bladder function in Parkinson's disease
Winge, K., Werdelin, L., Nielsen, K. K., & Stimpel, H. (2004) · Neurourology and Urodynamics · doi:10.1002/nau.20054 · Cited by 101
Lim, A., Leow, L., Huckabee, M., Frampton, C. M., & Anderson, T. (2007) · Dysphagia · doi:10.1007/s00455-007-9100-9 · Cited by 97
Non motor off in Parkinson's disease: Non motor off in PD
Raudino, F. (2001) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2001.00357.x · Cited by 92
Nociceptive brain activation in patients with neuropathic pain related to Parkinson's disease
Brefel‐Courbon, C., Ory‐Magne, F., Thalamas, C., Payoux, P., & Rascol, O. (2013) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2013.02.003 · Cited by 88
Letter, M. D., Santens, P., Bodt, M. S. D., Maele, G. V., Borsel, J. V., & Boon, P. (2007) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2007.04.003 · Cited by 86
Differential genetic susceptibility in diphasic and peak‐dose dyskinesias in Parkinson's disease
Lee, J., Cho, J., Lee, E., Park, S. S., & Jeon, B. S. (2010) · Movement Disorders · doi:10.1002/mds.23400 · Cited by 85
Pattern of subclinical pulmonary dysfunctions in Parkinson's disease and the effect of levodopa
Pal, P. K., Sathyaprabha, T. N., Tuhina, P., & Thennarasu, K. (2007) · Movement Disorders · doi:10.1002/mds.21330 · Cited by 85
Does levodopa improve swallowing dysfunction in Parkinson’s disease patients?
Menezes, C. A., & Melo, A. D. S. (2009) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2009.01031.x · Cited by 84
STIMULUS-SENSITIVE MYOCLONUS IN AKINETIC-RIGID SYNDROMES
Chen, R. E., Ashby, P., & Lang, A. E. (1992) · Brain · doi:10.1093/brain/115.6.1875 · Cited by 79
Severity of Parkinson's disease is a risk factor for peak-dose dyskinesia.
Horstink, M. W. I. M., Zijlmans, J. C. M., Pasman, J. W., et al. (1990) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.53.3.224 · Cited by 76
Sweating in Parkinsonian patients with wearing‐off
Pursiainen, V., Haapaniemi, T., Korpelainen, J. T., Sotaniemi, K. A., & Myllylä, V. V. (2007) · Movement Disorders · doi:10.1002/mds.21422 · Cited by 74
Does an inhibitory action of levodopa contribute to motor fluctuations?
Nutt, J. G., Gancher, S., & Woodward, W. R. (1988) · Neurology · doi:10.1212/wnl.38.10.1553 · Cited by 74
Sage, J. I., & Mark, M. H. (1995) · Annals of Neurology · doi:10.1002/ana.410370124 · Cited by 70
Age of Parkinson's disease onset as a predictor for the development of dyskinesia
Ku, S., & Glass, G. A. (2010) · Movement Disorders · doi:10.1002/mds.23068 · Cited by 69
Akathisia in Parkinson's disease
Comella, C. L., & Goetz, C. G. (1994) · Movement Disorders · doi:10.1002/mds.870090507 · Cited by 69
Cheshire, P., Bertram, K., Ling, H., et al. (2013) · Neurodegenerative Diseases · doi:10.1159/000351097 · Cited by 68
Respiratory Muscle Performance and the Perception of Dyspnea in Parkinson's Disease
WEINER, P., Inzelberg, R., Davidovich, A., Nisipeanu, P., Magadle, R., Yanay, N. B., & Carasso, R. L. (2002) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s031716710000175x · Cited by 67
Gender effect on time to levodopa-induced dyskinesias
Hassin‐Baer, S., Molchadski, I., Cohen, O. S., Nitzan, Z., Ephraty, L., Tunkel, O., Kozlova, E., & Korczyn, A. D. (2011) · Journal of Neurology · doi:10.1007/s00415-011-6067-0 · Cited by 65
Pietracupa, S., Fasano, A. A., Fabbrini, G., Sarchioto, M., Bloise, M. C., Latorre, A., Altieri, M., Bologna, M., & Berardelli, A. (2013) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2013.07.002 · Cited by 64
Pharmacological treatment and the prospect of pharmacogenetics in Parkinson’s disease
Kalinderi, K., Fidani, L., Katsarou, Z., & Bostantjopoulou, S. (2011) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2011.02793.x · Cited by 61
Sage, J. I. (2004) · Current Treatment Options in Neurology · doi:10.1007/s11940-004-0011-x · Cited by 59
The Clinical Profile of Nonmotor Fluctuations in Parkinson's Disease Patients
Günal, D. İ., Nurichalichi, K., Tuncer, N., Bekiroğlu, N., & Aktan, S. (2002) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100001736 · Cited by 57
Merello, M., & Lees, A. J. (1992) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.11.1024 · Cited by 45
Respiratory dyskinesia in Parkinson's disease
Jankovic, J. J., & Nour, F. (1986) · Neurology · doi:10.1212/wnl.36.2.303-b · Cited by 43
Brittle Dyskinesia Following STN but not GPi Deep Brain Stimulation
Sriram, A., Foote, K. D., Oyama, G., Kwak, J., Zeilman, P., & Okun, M. S. (2014) · Tremor and Other Hyperkinetic Movements · doi:10.5334/tohm.183 · Cited by 43
Variations in the "on-off" phenomenon.
Duvoisin, R. C. (1974) · PubMed · Cited by 42
Early Morning Off-Medication Dyskinesias, Dystonia, and Choreic Subtypes
Cubo, E., Graciès, J., Benabou, R., Olanow, C. W., Raman, R., Leurgans, S. E., & Goetz, C. G. (2001) · Archives of Neurology · doi:10.1001/archneur.58.9.1379 · Cited by 41
Stridor during dystonic phases of Parkinson's disease.
Corbin, D. O. C., & Williams, A. C. (1987) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.50.6.821 · Cited by 37
Painful dystonic spasms in Parkinson's disease.
Ilson, J., Fahn, S., & Cote, L. J. (1984) · PubMed · Cited by 37
Melamed, E., Bitton, V., & Zelig, O. (1986) · Clinical Neuropharmacology · doi:10.1097/00002826-198604000-00009 · Cited by 36
Parkinsonian Patients and Poor Awareness of Dyskinesias
Pietracupa, S., Latorre, A., Berardelli, A., & Fabbrini, G. (2014) · Frontiers in Neurology · doi:10.3389/fneur.2014.00032 · Cited by 33
Schuh, A. F. S., Altmann, V., Rieck, M., Tovo‐Rodrigues, L., Monte, T. L., Callegari-Jacques, S. M., Medeiros, M. S., Rieder, C. R. D. M., & Hutz, M. H. (2013) · The Pharmacogenomics Journal · doi:10.1038/tpj.2013.37 · Cited by 33
Zupnick, H. M., Brown, L. K., Miller, A., & Moros, D. A. (1990) · The American Journal of Medicine · doi:10.1016/0002-9343(90)90109-q · Cited by 31
Rich, M. W., & Radwany, S. M. (1994) · CHEST Journal · doi:10.1378/chest.105.6.1826 · Cited by 31
Levodopa‐induced ocular dyskinesias in Parkinson's disease
Linazasoro, G., Blercom, N. V., Lasa, A., Indakoetxea, B., & Ruiz, J. (2002) · Movement Disorders · doi:10.1002/mds.10017 · Cited by 28
End‐of‐dose dystonia in Parkinson's disease
Bravi, D., Mouradian, M. M., Roberts, J. W., Davis, T. L., & Chase, T. N. (1993) · Neurology · doi:10.1212/wnl.43.10.2130 · Cited by 21
Acute genital pain during non‐motor fluctuations improved by apomorphine
Lefaucheur, R., Berthelot, L., Sénant, J., Borden, A., & Maltête, D. (2013) · Movement Disorders · doi:10.1002/mds.25379 · Cited by 19
Acute Hypernatremia and Neuroleptic Malignant Syndrome in Parkinson Disease
Cao, L., & Katz, R. H. (1999) · The American Journal of the Medical Sciences · doi:10.1016/s0002-9629(15)40575-0 · Cited by 13
Novel Insights in Pharmacogenetics of Drug Response in Parkinson‘s Disease
Arbouw, M. E. L., Guchelaar, H., & Egberts, T. C. G. (2010) · Pharmacogenomics · doi:10.2217/pgs.09.175 · Cited by 11
Clinical and Experimental Experiences of Graft-Induced Dyskinesia
Lane, E. L. (2011) · International review of neurobiology · doi:10.1016/b978-0-12-381328-2.00007-9 · Cited by 10
Cited by
Obeso, J. A., Stamelou, M., Goetz, C. G., Poewe, W., Lang, A. E., Weintraub, D., Burn, D., Halliday, G. M., Bezard, E., Przedborski, S., et al. (2017) · Movement Disorders · doi:10.1002/mds.27115 · Cited by 859
“Motor complications (ie, fluctuations and dyskinesias) associated with chronic levodopa therapy represent a major challenge in the treatment of patients with PD.(177,178) In a large, prospective study, 29% of 352 patients originally enrolled in the Deprenyl and Tocopherol Antioxidative Therapy of Parkinsonism (DATATOP…”
Motor and Nonmotor Complications of Levodopa: Phenomenology, Risk Factors, and Imaging Features
Ray Chaudhuri, K., Poewe, W., & Brooks, D. (2018) · Movement Disorders · doi:10.1002/mds.27386 · Cited by 121
Zhao, Y., Zhang, Z., Qin, S., Fan, W., Li, W., Liu, J., Wang, S., Xu, Z., & Zhao, M. (2021) · Neural Plasticity · doi:10.1155/2021/9926445 · Cited by 68
Pharmacologic Treatment of Motor Symptoms Associated with Parkinson Disease
Poewe, W., & Mahlknecht, P. (2020) · Neurologic Clinics · doi:10.1016/j.ncl.2019.12.002 · Cited by 60
Metadata
- Authors
- Aquino, C. C., & Fox, S. H.
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2014-12-08
- Volume
- 30
- Issue
- 1
- Pages
- 80-89
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W1537019834
- Cited by
- 270
- References
- 114
- FWCI
- 12.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.